What Are We Learning From Early-Phase Clinical Trials With Glutamate Targeting Medications for the Treatment of Major Depressive Disorder

JAMA Psychiatry. 2016 Jul 1;73(7):651-2. doi: 10.1001/jamapsychiatry.2016.0780.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antidepressive Agents
  • Depressive Disorder, Major*
  • Glutamic Acid*
  • Humans

Substances

  • Antidepressive Agents
  • Glutamic Acid